| Bioactivity | PNU-145156E (FCE26644) is an angiogenesis inhibitor with anti-tumor activity. PNU-145156E inhibits the binding of bFGF to its receptor and inhibits bFGF-induced endothelial cell proliferation and motility[1]. |
| CAS | 154788-16-6 |
| Formula | C45H36N10Na4O17S4 |
| Molar Mass | 1209.04 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Groen H J M, et al. PNU-145156E, a novel angiogenesis inhibitor, in patients with solid tumors: a phase I and pharmacokinetic study[J]. Clinical cancer research, 2001, 7(12): 3928-3933. |
PNU-145156E
CAS: 154788-16-6 F: C45H36N10Na4O17S4 W: 1209.04
PNU-145156E (FCE26644) is an angiogenesis inhibitor with anti-tumor activity. PNU-145156E inhibits the binding of bFGF t
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.